| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Division of Cardiology, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032
Metabolic interventions that promote glucose use during ischemia have been shown to protect ischemic myocardium and improve functional recovery on reperfusion. We evaluated whether the cardioprotection afforded by high glucose during low-flow ischemia is associated with changes in the sarcolemmal content of glucose transporters, specifically GLUT-4. Isolated rat hearts were paced at 300 beats/min and perfused under normal glucose (5 mM) or high glucose (10 mM) conditions in buffer containing 0.4 mM albumin, 0.4 mM palmitate, and 70 mU/l insulin and subjected to 50 min of low-flow ischemia and 60 min of reperfusion. To determine the importance of insulin-sensitive glucose transporters in mediating cardioprotection, a separate group of hearts were perfused in the presence of cytochalasin B (10 µM), a preferential inhibitor of insulin-sensitive glucose transporters. Ischemic contracture during low-flow ischemia and creatine kinase release on reperfusion was decreased, and the percent recovery of left ventricular function with reperfusion was enhanced in hearts perfused with high glucose (P < 0.03). Hearts perfused with high glucose exhibited increased GLUT-4 protein expression in the sarcolemmal membrane compared with control hearts under baseline conditions, and these changes were additive with low-flow ischemia. In addition, high glucose did not affect the baseline distribution of sarcolemmal GLUT-1 and blunted any changes with low-flow ischemia. These salutary effects were abolished when glucose transporters are blocked with cytochalasin B. These data demonstrate that protection of ischemic myocardium by high glucose is associated with increased sarcolemmal content of the insulin-sensitive GLUT-4 and suggest a target for the protection of jeopardized myocardium.
insulin-sensitive glucose transporters; metabolism
This article has been cited by other articles:
|
|
 |
|
  R. Ananthakrishnan, M. Kaneko, Y. C. Hwang, N. Quadri, T. Gomez, Q. Li, C. Caspersen, and R. Ramasamy Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H333 - H341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Morais, J. Westhuyzen, B. Pat, G. Gobe, and H. Healy High ambient glucose is effect neutral on cell death and proliferation in human proximal tubular epithelial cells Am J Physiol Renal Physiol, August 1, 2005; 289(2): F401 - F409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Quinn, D. Pagano, and R. S. Bonser Glucose and Insulin Influences on Heart and Brain in Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2005; 9(2): 173 - 178. [Abstract] [PDF]
|
|
|
|
 |
|
 T. L. Collier, Y. Hwang, R. Ramasamy, R. R. Sciacca, K. T. Hickey, N. R. Simpson, and S. R. Bergmann Synthesis and Initial Evaluation of 17-11C-Heptadecanoic Acid for Measurement of Myocardial Fatty Acid Metabolism J. Nucl. Med., December 1, 2002; 43(12): 1707 - 1714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Lankford, A. M. Byford, K. J. Ashton, B. A. French, J. K. Lee, J. P. Headrick, and G. P. Matherne Gene expression profile of mouse myocardium with transgenic overexpression of A1 adenosine receptors Physiol Genomics, October 29, 2002; 11(2): 81 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Sidell, M. A. Cole, N. J. Draper, M. Desrois, R. E. Buckingham, and K. Clarke Thiazolidinedione Treatment Normalizes Insulin Resistance and Ischemic Injury in the Zucker Fatty Rat Heart Diabetes, April 1, 2002; 51(4): 1110 - 1117. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
